Stockholders' Deficit - Schedule of Warrants Activity (Details) - Warrants [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Number of warrants, Outstanding, Beginning balance | 63,452,536 | 5,307,051 |
| Number of warrants, Increase during the period as a result of down round provisions | 4,507,712,672 | 58,220,985 |
| Number of warrants, Warrants expired | (1) | (75,500) |
| Number of warrants, Outstanding, Ending balance | 4,571,165,207 | 63,452,536 |
| Weighted average exercise price, Warrants outstanding, Beginning balance | $ 1.44 | $ 17.26 |
| Weighted average exercise price, Warrants Increase during the period as a result of down round provisions | ||
| Weighted average exercise price, Warrants expired | (3,150) | (3.36) |
| Weighted average exercise price, Warrants outstanding, Ending balance | $ 0.02 | $ 1.44 |
| X | ||||||||||
- Definition Weighted average exercise price, warrants outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock warrants of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, Warrants Increase during the period as a result of down round provisions. No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Increase (decrease) in the number of shares under non-option equity instrument agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|